Kuldeep Neote

Kuldeep Neote possesses extensive experience in the biotechnology and pharmaceutical sectors, currently serving as Entrepreneur In Residence at The National Institutes of Health, Commercialization at UHN, and FACIT/OICR since July 2021 and August 2022, respectively. Previously, Kuldeep held the position of Vice President External Innovation at Eli Lilly and Company from April 2019 to June 2021 and Senior Director of New Ventures at Johnson & Johnson from September 2017 to April 2019, where Kuldeep also acted as Interim Head of JLABS@Canada. Additional roles include Senior Director-New Ventures at the J&J Innovation Center-Boston and Research Advisor at Eli Lilly. Earlier in the career, Kuldeep served as Principal Research Investigator and Principal Research Scientist at Pfizer Inc. and Pfizer Global R&D. Kuldeep holds a Doctor of Philosophy (PhD) in Molecular Genetics from the University of Toronto, obtained between 1982 and 1989.